A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a randomized, placebo‐controlled, double‐blind, crossover study of oral BTD‐001 in adults with Idiopathic Hypersomnia (IH). The objectives of this study are two‐fold: 1) To evaluate the efficacy of BTD‐001 in subjects with IH as reflected by changes in cognitive, sleep, functional, and quality‐of‐life measures and 2) To characterize the safety and tolerability of oral BTD‐001 administered to subjects with IH.
Epistemonikos ID: edf379b0f9c5a7afe3005e16d0375412b9aa7cd6
First added on: May 21, 2024